Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.05.2023 | Case report

Antineoplastics

Anaemia, thrombocytopenia and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ngu S-F, et al. A patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report. Cancer Drug Resistance 5: 662-666, No. 3, 22 Jun 2022. Available from: URL: https://cdrjournal.com/article/view/4784 Ngu S-F, et al. A patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report. Cancer Drug Resistance 5: 662-666, No. 3, 22 Jun 2022. Available from: URL: https://​cdrjournal.​com/​article/​view/​4784
Metadaten
Titel
Antineoplastics
Anaemia, thrombocytopenia and lack of efficacy: case report
Publikationsdatum
01.05.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38283-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Multiple drugs